Status:
COMPLETED
Text Messaging to Improve Adherence to Clinic Visits and Reduce Early Resumption of Sexual Intercourse After Male Circumcision
Lead Sponsor:
University of Washington
Collaborating Sponsors:
University of Illinois at Chicago
Kenya Medical Research Institute
Conditions:
HIV Infections
Acquired Immunodeficiency Syndrome
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
Male circumcision (MC) reduces, by more than half, the risk of HIV-1 acquisition. WHO and UNAIDS recommend that "male circumcision should be recognized as an efficacious intervention for HIV preventio...
Eligibility Criteria
Inclusion
- Male
- 18 years or older
- Have undergone circumcision on the day they are screened for the study
- Currently own a mobile phone with text-messaging capability, and
- Have the mobile phone in their possession at the time of enrollment
- Able and willing to respond to a questionnaire administered via a phone call
Exclusion
- Prior participation in a study on male circumcision
- Currently participating in other ongoing research studies
- Any medical condition or situation exists such that study participation would not be in the man's best interest, as determined by the investigator
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT01186575
Start Date
August 1 2010
End Date
June 1 2011
Last Update
January 16 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nyanza Reproductive Health Society
Kisumu, Nyanza, Kenya